ArticleFrontiers in pharmacology2025

Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells.

Ye Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.